scPharmaceuticals Statistics
Total Valuation
SCPH has a market cap or net worth of $202.72 million. The enterprise value is $197.18 million.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SCPH has 52.79 million shares outstanding. The number of shares has increased by 24.22% in one year.
| Current Share Class | 52.79M |
| Shares Outstanding | 52.79M |
| Shares Change (YoY) | +24.22% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 6.30% |
| Owned by Institutions (%) | 42.18% |
| Float | 31.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.41 |
| Forward PS | 2.25 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.48
| Current Ratio | 5.48 |
| Quick Ratio | 4.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.73 |
Financial Efficiency
Return on equity (ROE) is -934.02% and return on invested capital (ROIC) is -74.02%.
| Return on Equity (ROE) | -934.02% |
| Return on Assets (ROA) | -49.20% |
| Return on Invested Capital (ROIC) | -74.02% |
| Return on Capital Employed (ROCE) | -89.32% |
| Revenue Per Employee | $255,988 |
| Profits Per Employee | -$553,549 |
| Employee Count | 164 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 1.10 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.76% in the last 52 weeks. The beta is 0.36, so SCPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -3.76% |
| 50-Day Moving Average | 3.10 |
| 200-Day Moving Average | 3.55 |
| Relative Strength Index (RSI) | 56.83 |
| Average Volume (20 Days) | 302,249 |
Short Selling Information
The latest short interest is 2.08 million, so 3.93% of the outstanding shares have been sold short.
| Short Interest | 2.08M |
| Short Previous Month | 2.54M |
| Short % of Shares Out | 3.93% |
| Short % of Float | 6.57% |
| Short Ratio (days to cover) | 5.08 |
Income Statement
In the last 12 months, SCPH had revenue of $41.98 million and -$90.78 million in losses. Loss per share was -$1.88.
| Revenue | 41.98M |
| Gross Profit | 28.94M |
| Operating Income | -66.68M |
| Pretax Income | -57.71M |
| Net Income | -90.78M |
| EBITDA | -66.66M |
| EBIT | -66.68M |
| Loss Per Share | -$1.88 |
Full Income StatementBalance Sheet
The company has $57.90 million in cash and $52.36 million in debt, giving a net cash position of $5.54 million or $0.10 per share.
| Cash & Cash Equivalents | 57.90M |
| Total Debt | 52.36M |
| Net Cash | 5.54M |
| Net Cash Per Share | $0.10 |
| Equity (Book Value) | -5.13M |
| Book Value Per Share | -0.10 |
| Working Capital | 73.04M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$69.98 million and capital expenditures -$21,000, giving a free cash flow of -$70.00 million.
| Operating Cash Flow | -69.98M |
| Capital Expenditures | -21,000 |
| Free Cash Flow | -70.00M |
| FCF Per Share | -$1.33 |
Full Cash Flow StatementMargins
Gross margin is 68.92%, with operating and profit margins of -158.82% and -216.24%.
| Gross Margin | 68.92% |
| Operating Margin | -158.82% |
| Pretax Margin | -216.24% |
| Profit Margin | -216.24% |
| EBITDA Margin | -158.78% |
| EBIT Margin | -158.82% |
| FCF Margin | n/a |
Dividends & Yields
SCPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.22% |
| Shareholder Yield | -24.22% |
| Earnings Yield | -44.78% |
| FCF Yield | -34.53% |
Analyst Forecast
The average price target for SCPH is $14.00, which is 264.58% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 264.58% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 55.07% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SCPH has an Altman Z-Score of -5.8 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.8 |
| Piotroski F-Score | 2 |